ANCHOR presentation at ASH 2020
December 6, 2020
Oncopeptides presented new data from phase 2 ANCHOR combination study in multiple myeloma the 62nd American Society of Hematology virtual annual meeting ASH, December 6, 2020.
See presentation below.
-
Change Region
-
Global
-
United States
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our US operations, Oncopeptides Inc. at oncopeptides-us.com
-
Germany
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de
Change Language
-
-
ONCO4.19 SEK-7.7%-0.35 SEK
-
-
Change Region
-
Global
-
United States
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our US operations, Oncopeptides Inc. at oncopeptides-us.com
-
Germany
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de
Change Language
-
-
ONCO4.19 SEK-7.7%-0.35 SEK
-